Jaguar Health announced launch of the first U.S. Canine Cancer Registry and Canine Cancer Care Index
On May 23, 2022, Jaguar Health announced the launch of Canine Cancer: Take C.H.A.R.G.E. (Canine Health And ReGistry…
WHO announced nulti-country monkeypox outbreak in non-endemic countries
On May 21, 2022, the WHO announced that since May 13, 2022, cases of monkeypox had been reported…
NIH announced antiviral drug development awards
On May 18, 2022, the U.S. National Institutes of Health announced it had awarded approximately $577 million to…
WHO validated 11th vaccine for COVID-19
On May 19, 2022, WHO issued an emergency use listing (EUL) for CONVIDECIA, a vaccine manufactured by CanSino…
Study found ‘natural immunity’ from Omicron weak and limited
On May 18, 2022, researchers at Gladstone Institutes and UC San Francisco (UCSF) reported that unvaccinated people, infection…
SARS-CoV-2 RNA can persist in stool months after respiratory tract clears virus
On May 18, 2022, SARS-CoV-2, or at least pieces of it, sticks around longer in some infected individuals…
InteliSwabﾮ COVID-19 rapid test validated to detect Omicron BA.2, BA.2.12.1, BA.3 and BA.5 subvariants
On May 17, 2022, OraSure Technologies announced that its InteliSwabﾮ COVID-19 rapid tests detect the Omicron BA.2, BA.2.12.1,…
Pfizer and BioNTech granted U.S. EUA for booster dose of COVID-19 vaccine in children 5 through 11 years of age
On May 17, 2022, Pfizer and BioNTech announced the U.S. Food and Drug Administration expanded emergency use authorization…
TGen worked with Arizona zoos and state and federal wildlife agencies to test wild animals for SARS-CoV-2
On May 16, 2022, working with state and federal wildlife agencies and private and public zoos across Arizona,…
Cepheid received Emergency Use Authorization for Xpertﾮ Xpress CoV-2 plus
On May 12, 2022, Cepheid announced it had received Emergency Use Authorization from the U.S. Food & Drug…
NIH licensed COVID-19 research tools and early-stage technologies to WHO program
On May 12, 2022, the U.S. National Institutes of Health announced that it had licensed 11 COVID-19 research…
WHO and Medicines Patent Pool announced agreement with NIH for COVID-19 health technologies
On May 12, 2022, WHOﾒs COVID-19 Technology Access Pool and the Medicines Patent Pool finalized a licensing agreement…
Lucira filed for authorization of first-of-its-Kind COVID-19 & flu at-home molecular test
On May 11, 2022, Lucira Health announced that it had submitted a request to the U.S. Food and…
Lucira received CE Mark for both COVID-19 & flu and COVID-19 molecular tests
On May 9, 2022, Lucira Health announced that both its COVID-19 & Flu and COVID-19 molecular tests have…
WHO informed of a confirmed case of monkeypox in an individual who travelled from the United Kingdom to Nigeria
On May 7, 2022, WHO was informed of a confirmed case of monkeypox in an individual who travelled…
NIH launched clinical trial of Epstein-Barr virus vaccine
On May 6, 2022, the National Institute of Allergy and Infectious Diseases (NIAID) announced that it had launched…
WHO reported 14.9 million excess deaths associated with the COVID-19 pandemic in 2020 and 2021
On May 5, 2022, the World Health Organization (WHO) reported estimates that show the full death toll associated…
U.S. EPA and State of Florida approved second pilot project with Oxitec Friendlyﾙ mosquitoes in the Florida Keys
On May 4, 2022, Oxitec announced approval from the Florida Department of Agriculture and Consumer Services, including reviews…
USDA issued a conditional license for mink Coronavirus
On Apr. 27, 2022, the U.S. Department of Agricultureﾒs Animal and Plant Health Inspection Service announced it had…
Evolution of DNA
he Evolution of DNA is an Illustration with the very small, requiring magnification, to the very large. Cast…
Codiak announced new preclinical data supporting development of broadly protective pan beta-Coronavirus vaccine
On Apr. 20, 2022, Codiak BioSciences announced new preclinical data from its pan beta-coronavirus vaccine program, which aims…
Pfizer and BioNTech data demonstrated high immune response following booster dose of COVID-19 vaccine in children 5 through 11 years of age
On Mar. 14, 2022, Pfizer and BioNTech announced positive results from a Phase 2/3 clinical trial evaluating the…
Regeneron antibody cocktail approved by European Commission to treat and prevent COVID-19
On Nov. 12, 2021, Regeneron announced that the U.S. Food and Drug Administration had extended by three months…
FDA authorized first COVID-19 diagnostic test using breath samples
On Apr. 14, 2022, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the…
Merck announced FDA granted breakthrough therapy designation for V116, investigational 21-valent pneumococcal conjugate vaccine, for prevention of invasive pneumococcal disease and pneumococcal pneumonia in adults
On Apr. 14, 2022, Merck announced that V116, the companyﾒs investigational 21-valent pneumococcal conjugate vaccine, had received Breakthrough…
FDA announced legislation clarifying the agency can regulate tobacco products containing nicotine from any source
On Apr. 13, 2022, the U.S. Food and Drug Administration announced that the legislation clarifying the agency can…
Veruﾒs novel COVID-19 drug candidate reduced deaths by 55% in hospitalized patients in interim analysis of phase 3 study
On Apr. 11, 2022, Veru announced positive efficacy and safety results from a planned interim analysis of the…
BioNTech granted pandemic preparedness contract by German Federal Ministry of Health
On Apr. 9, 2022, BioNTech announced it was granted a pandemic preparedness contract by the Federal Republic of…
NIH funded new tuberculosis research advancement centers
On Mar. 9, 2022, the National Institute of Allergy and Infectious Diseases (NIAID) announced four grant awards to…
Sorrento reported FDA clearance for phase 2/3 study for Abivertinib in treatment of pospitalized patients with severe pneumonia due to COVID-19
On Mar. 31, 2022, Sorrento Therapeutics announced that the FDA had given clearance to commence the Phase 3…